Braf Mutation V600 | List of Frontiers open access articles

Original Research

Published on 21 Feb 2024

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience

in Skin Cancer

Chen Sun
Sofia España
Nina Richarz
Carme Solé-Blanch
Aram Boada
Anna Martinez-Cardús
Alan Chu
Zongwen Liu
Jose Luis Manzano

Frontiers in Oncology

doi 10.3389/fonc.2024.1322116

4,276 views
6 citations

Case Report

Published on 09 Jul 2024

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report

in Cancer Endocrinology

Daniele Barbaro
Raffaella Forleo
Maria Antonietta Profilo
Paola Lapi
Carlotta Giani
Liborio Torregrossa
Elisabetta Macerola
Gabriele Materazzi

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1389294

3,969 views
7 citations

Mini Review

Published on 26 Jan 2022

Dramatic Therapeutic Response to Dabrafenib Plus Trametinib in BRAF V600E Mutated Papillary Craniopharyngiomas: A Case Report and Literature Review

in Precision Medicine

Morena Fasano
Carminia Maria Della Corte
Marianna Caterino
Mario Pirozzi
Raffaele Rauso
Teresa Troiani
Giulia Martini
Stefania Napolitano
Floriana Morgillo
Fortunato Ciardiello

Frontiers in Medicine

doi 10.3389/fmed.2021.652005

4,466 views
15 citations

Case Report

Published on 16 Dec 2021

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

in Pharmacology of Anti-Cancer Drugs

Su Min Cho
Abdullah Esmail
Maen Abdelrahim

Frontiers in Pharmacology

doi 10.3389/fphar.2021.795381

4,976 views
11 citations

Mini Review

Published on 14 Aug 2023

Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review

in Thoracic Oncology

Megha Puri
Kunal Gawri
Richa Dawar

Frontiers in Oncology

doi 10.3389/fonc.2023.1141876

9,873 views
17 citations

Original Research

Published on 09 Dec 2024

BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression

in Thyroid Endocrinology

Ana-Maria Sigarteu Chindris
Michael Rivera
Yaohua Ma
Asha Nair
Yi Liu
Xue Wang
Brian M. Necela
Jennifer M. Kachergus
John D. Casler
Christopher Brett

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1440722

3,493 views
3 citations

Original Research

Published on 07 Jun 2023

Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiency

in Gastrointestinal Cancers: Colorectal Cancer

Eric S. Christenson
Hua-Ling Tsai
Dung T. Le
Elizabeth M. Jaffee
Jonathan Dudley
Rena R. Xian
Christopher D. Gocke
James R. Eshleman
Ming-Tseh Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1193259

3,851 views
16 citations

Case Report

Published on 10 Jul 2020

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report

in Skin Cancer

Francesca Consoli
Gianluca Barbieri
Matteo Picciolini
Daniela Medicina
Mattia Bugatti
Valeria Tovazzi
Barbara Liserre
Claudia Zambelli
Fausto Zorzi
Alfredo Berruti

Frontiers in Oncology

doi 10.3389/fonc.2020.01056

10,882 views
6 citations

Mini Review

Published on 25 Jan 2021

Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions

in Head and Neck Cancer

Ashleigh Porter
Deborah J. Wong

Frontiers in Oncology

doi 10.3389/fonc.2020.592202

12,395 views
59 citations

Articles

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report

Dramatic Therapeutic Response to Dabrafenib Plus Trametinib in BRAF V600E Mutated Papillary Craniopharyngiomas: A Case Report and Literature Review

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review

BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression

Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiency

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report

Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions